Literature DB >> 7116159

The distribution of alterations in energy metabolism in the rat brain produced by apomorphine.

J McCulloch, H E Savaki, M C McCulloch, J Jehle, L Sokoloff.   

Abstract

The effects of the putative dopaminergic agonist, apomorphine (0.15-5 mg/kg, i.v.), on glucose utilization in 43 anatomically discrete regions of the rat brain have been examined by the quantitative autoradiographic 2-deoxyglucose technique. Apomorphine failed to alter the rates of glucose utilization in 25 of these regions (for example, primary auditory areas, regions of white matter, hippocampal areas, nucleus accumbens and caudal regions of the neocortex). Dose-dependent alterations in glucose utilization were observed following apomorphine administration in a number of regions known to contain dopaminergic receptors (viz: caudate nucleus, substantia nigra, amygdala, subthalamic nucleus and anterior cingulate cortex). Moreover, dose-dependent alterations in glucose utilization were produced by apomorphine in a number of regions thought to contain few specific dopaminergic receptors (e.g., cerebellar hemisphere and vermis, lamina VI of rostral neocortical areas, and ventral nucleus of the thalamus). The distribution of alterations in glucose utilization following apomorphine administration are considered to reflect the functional involvement of the region in the overall response to apomorphine, and not simply the topography of dopaminergic receptor mechanisms.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7116159     DOI: 10.1016/0006-8993(82)91121-0

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  9 in total

Review 1.  Autoradiographic assessment of the effects of N-methyl-D-aspartate (NMDA) receptor antagonists in vivo.

Authors:  J McCulloch; L L Iversen
Journal:  Neurochem Res       Date:  1991-09       Impact factor: 3.996

Review 2.  Brain injury: new insights into neurotransmitter and receptor mechanisms.

Authors:  H M Pappius
Journal:  Neurochem Res       Date:  1991-09       Impact factor: 3.996

3.  Evaluation of a structural polymorphism in the ankyrin repeat and kinase domain containing 1 (ANKK1) gene and the activation of executive attention networks.

Authors:  John Fossella; Adam E Green; Jin Fan
Journal:  Cogn Affect Behav Neurosci       Date:  2006-03       Impact factor: 3.282

4.  The effects of cocaine on regional brain glucose metabolism is attenuated in dopamine transporter knockout mice.

Authors:  Panayotis K Thanos; Michael Michaelides; Helene Benveniste; Gene Jack Wang; Nora D Volkow
Journal:  Synapse       Date:  2008-05       Impact factor: 2.562

5.  Imaging apomorphine stimulation of brain arachidonic acid signaling via D2-like receptors in unanesthetized rats.

Authors:  Abesh Kumar Bhattacharjee; Lisa Chang; Laura White; Richard P Bazinet; Stanley I Rapoport
Journal:  Psychopharmacology (Berl)       Date:  2008-02-15       Impact factor: 4.530

6.  PET measurement of dopamine D2 receptor-mediated changes in striatopallidal function.

Authors:  K J Black; M H Gado; J S Perlmutter
Journal:  J Neurosci       Date:  1997-05-01       Impact factor: 6.167

7.  Local cerebral glucose utilisation in treated and untreated patients with Parkinson's disease.

Authors:  D Rougemont; J C Baron; P Collard; P Bustany; D Comar; Y Agid
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-08       Impact factor: 10.154

8.  Altered thalamic response to levodopa in Parkinson's patients with dopa-induced dyskinesias.

Authors:  T Hershey; K J Black; M K Stambuk; J L Carl; L A McGee-Minnich; J S Perlmutter
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-29       Impact factor: 11.205

9.  Assessing the molecular genetics of attention networks.

Authors:  John Fossella; Tobias Sommer; Jin Fan; Yanhong Wu; James M Swanson; Donald W Pfaff; Michael I Posner
Journal:  BMC Neurosci       Date:  2002-10-04       Impact factor: 3.288

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.